MedPath

Efficacy of Dark Chocolate in Achalasia Patients

Phase 1
Conditions
Achalasia
Interventions
Dietary Supplement: dark chocolate
Dietary Supplement: placebo chocolate with crossover to dark chocolate
Registration Number
NCT00790465
Lead Sponsor
Tel-Aviv Sourasky Medical Center
Brief Summary

Flavanols, present in dark chocolate, were shown to induce Nitric Oxide synthesis. Since Nitric Oxide facilitates smooth muscle relaxation, it might ease the relaxation of the LES (lower esophageal sphincter)as well.

The objective of the present study is to evaluate tha efficacy of dark chocolate in improving LES relaxation in achalasia patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • clinical diagnosis of "achalasia"
  • "Achalasia" diagnosis during manometry at day 1 of the study.
Exclusion Criteria
  • pregnancy
  • pseudoachalasia
  • consumption of GI-motility modifiers durin 72 hours preceding the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
1dark chocolatedark chocolate consumption during manometry and 2 weeks treatment with dark chocolate
2placebo chocolate with crossover to dark chocolateplacebo comparator: 7 grams of placebo-chocolate at day 1 during manometry, and than crossover to treatment with dark chocolate for 2 weeks.
Primary Outcome Measures
NameTimeMethod
Lower Esophageal Sphincter relaxation before and after dark chocolate consumption.day 1
Secondary Outcome Measures
NameTimeMethod
achalasia symptoms before and during dark-chocolate consumption2 weeks
© Copyright 2025. All Rights Reserved by MedPath